Stephen D Rubin
Overview
Explore the profile of Stephen D Rubin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
3404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Amsterdam L, Gentry W, Jobanputra S, Wolf M, Rubin S, Bulun S
Fertil Steril
. 2005 Aug;
84(2):300-4.
PMID: 16084868
Objective: To establish the use of aromatase inhibitors as a therapeutic option for endometriosis. Design: Prospective open-label Food and Drug Administration phase 2 trial with Institutional Review Board approval. Setting:...
12.
Dougherty R, Rohrer J, Hayden D, Rubin S, Leder B
Clin Endocrinol (Oxf)
. 2005 Jan;
62(2):228-35.
PMID: 15670201
Objective: Although androgen replacement has been shown to have beneficial effects in hypogonadal men, there is concern that androgens may deleteriously affect cardiovascular risk in elderly men. Design: Anastrozole is...
13.
Plourde P, Reiter E, Jou H, Desrochers P, Rubin S, B Bercu B, et al.
J Clin Endocrinol Metab
. 2004 Sep;
89(9):4428-33.
PMID: 15356042
Pubertal gynecomastia is thought to result from transient imbalances between estrogen and androgen concentrations. Anastrozole (ARIMIDEX), a potent and selective aromatase inhibitor, decreases estrogen and increases testosterone concentrations in pubertal...
14.
Leder B, Rohrer J, Rubin S, Gallo J, Longcope C
J Clin Endocrinol Metab
. 2004 Mar;
89(3):1174-80.
PMID: 15001605
As men age, serum testosterone levels decrease, a factor that may contribute to some aspects of age-related physiological deterioration. Although androgen replacement has been shown to have beneficial effects in...
15.
Eugster E, Rubin S, Reiter E, Plourde P, Jou H, Pescovitz O
J Pediatr
. 2003 Aug;
143(1):60-6.
PMID: 12915825
Objective: We undertook a 1-year multicenter trial of tamoxifen treatment for precocious puberty in girls with McCune-Albright syndrome (MAS). Study Design: Girls < or =10 years with classic or atypical...